Characteristic | n (%) |
---|---|
Middle Age (range) | 34 years old (18-50) |
Gender | |
Male | 1 (14.3) |
Female | 6 (85.7) |
Clinical staging | |
II | 2 (28.6) |
IV | 5 (71.4) |
Performance status score (Eastern Cooperative Oncology Group) | |
0 | 5 (71.4) |
1 | 1 (14.3) |
2 | 1 (14.3) |
International prognostic index | |
0-1 | 1 (14.3) |
2 | 4 (57.1) |
3 | 2 (28.6) |
Bulky disease (longest diameter ≥ 7.5 cm by CT scan) | |
Mediastinum | 5 (71.4) |
Abdominal cavity | 2 (28.6) |
B symptoms | |
Weight lose | 2 (28.6) |
Fever | 1 (14.3) |
Laboratory abnormalities | |
LDH (>240 IU/L) | 6 (85.7) |
C-reactive protein increased | 6 (85.7) |